Welcome to the Karanicolas lab


Our primary goal is to develop structure-based approaches for modulating protein function using small-molecules. We apply these new approaches in projects seeking to re-activate disabled tumor suppressors, inhibit oncogenic RNA-binding proteins, and tune the activity of antibodies used in cancer immunotherapy.


Harnessing the power of computational chemical biology to address non-traditional drug targets